Rebecca Byam insider trades

Open-market stock purchases and sales by Rebecca Byam, Chief Financial Officer at HCW Biologics Inc, from SEC Form 4 filings since Jul 22, 2021.

Recent trades

DateStockTradeValue
May 22, 2026HCWB HCW Biologics IncBought—

Companies traded

  • HCWB HCW Biologics Inc: 33 buys, last May 22, 2026

Get free alerts when Rebecca Byam files a new trade →